HomeEKSO • NASDAQ
Ekso Bionics Holdings Inc
$0.69
After Hours:
$0.73
(4.99%)+0.035
Closed: Nov 22, 5:20:18 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$0.72
Day range
$0.67 - $0.74
Year range
$0.67 - $3.13
Market cap
15.20M USD
Avg Volume
90.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
4.13M-10.38%
Operating expense
4.85M-10.01%
Net income
-2.07M38.42%
Net profit margin
-50.1831.30%
Earnings per share
EBITDA
-2.23M10.97%
Effective tax rate
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
8.29M-16.55%
Total assets
29.21M-6.33%
Total liabilities
14.34M-9.96%
Total equity
14.87M
Shares outstanding
22.00M
Price to book
1.06
Return on assets
-23.48%
Return on capital
-33.02%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
-2.07M38.42%
Cash from operations
-2.28M32.09%
Cash from investing
-8.00K52.94%
Cash from financing
4.69M
Net change in cash
2.41M171.42%
Free cash flow
-1.11M57.80%
About
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Founded
2005
Employees
70
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu